The first study included all patients who presented to the ENT and thoracic medicine departments with severe and persistent dysphonia while receiving inhaled steroids for asthma. A careful history of dysphonia was recorded, with particular reference to the onset and its relation to the start of treatment with inhaled steroids. The type and total daily dose of inhaled and oral treatment were noted and the patient's inhaler technique was scrutinised and graded " efficient" or " inefficient." "Efficiency" was recorded if the following criteria were fulfilled: (1) mixture of the aerosol contents by shaking; (2) depression of the actuator shortly after the start of a deep inspiration, followed by (3) breath holding for at least four seconds.
Inhaled steroids have an important and well established role in the treatment of chronic asthma. '-6 Troublesome side effects include candidiasis, sore throat, and dysphonia. These complications occur with all inhaled steroids '-'1 and are probably dose related.48 11 15 The incidence of these side effects is uncertain. The reported incidence of candidiasis ranges from zero '6-'9 to The first study included all patients who presented to the ENT and thoracic medicine departments with severe and persistent dysphonia while receiving inhaled steroids for asthma. A careful history of dysphonia was recorded, with particular reference to the onset and its relation to the start of treatment with inhaled steroids. The type and total daily dose of inhaled and oral treatment were noted and the patient's inhaler technique was scrutinised and graded " efficient" or " inefficient." "Efficiency" was recorded if the following criteria were fulfilled: (1) mixture of the aerosol contents by shaking; (2) depression of the actuator shortly after the start of a deep inspiration, followed by (3) breath holding for at least four seconds.
In each patient an independent assessment of dysphonia was made by two speech therapists after an interview and analysis of the patient's voice recordings. Specific inquiry was made about smoking, shouting, coughing, loud voice, noise during work, family deafness, and excessive throat clearing.
The patient was considered to have vocal abuse if three or more of these factors were present. The same criteria for vocal abuse were applied to a 813 814 random sample of people attending a hospital outpatient department. The severity of dysphonia was scored for each patient on a scale of 0-4, zero denoting normal phonation and 4 the most severe dysphonia short of aphonia.
In all cases an examination of the pharynx and larynx was undertaken. Naked eye appearances were documented and a throat swab was taken for mycological study. The presence of fungus was recorded if colonies were grown in Sabouraud's medium after culture for 24-48 hours. The larynx was examined by standard mirror (indirect) laryngoscopy supplemented by direct fibreoptic examination, the latter after the application of local anaesthetic (25% cocaine paste) to the nasal fossae and lignocaine spray to the oropharynx and postnasal space. Care was taken that no anaesthetic was applied to the larynx. The appearances and movements of the vocal cords were documented and photographs taken during deep inspiration (abduction) and phonation (adduction). There was excellent agreement between the two speech therapists in their scoring of the grade of dysphonia. On only one occasion in one patient did their assessments differ and then by only one grade.
Direct laryngoscopy invariably gave a good view of the larynx whereas indirect examination failed to give any view in three patients because the epiglottis obscured vision. In nine patients a characteristic bilateral adductor vocal cord abnormality ("bowing" on phonation) was seen on laryngoscopy. An example of this abnormality with normal vocal cord appearances for comparison is shown in figure 1 immediately while in another (No 4) it appeared only after 112 weeks. There was no significant correlation between the duration of treatment and the grade of dysphonia at presentation. had dysphonia for three months. The adduction deformity had resolved by eight weeks after the inhaled steroid had been stopped. The patient thought that his voice had returned to normal within the first week after he had stopped inhaling steroid, although dysphonia as assessed by speech therapists persisted for eight weeks. Inhalation of salbutamol as a dry powder was continued throughout and the dose of prednisolone remained unchanged. In patient 6 (fig 4) the patient had received beclomethasone dipropionate for eight weeks and had had dysphonia for six weeks. Discontinuation of inhaled steroid led to the improvement and eventual disappearance of the dysphonia and the vocal cord deformity at six weeks. At follow up examination eight weeks later the patient remained symptom free with a normal laryngeal appearance. Commencement of treatment with another inhaled steroid, betamethasone valerate, led to a return of the adduction deformity and dysphonia. A summary of events for all nine patients is shown in table 4. There was a strong correlation between the times taken for the recovery of normal vocal cord function and of normal phonation as judged by the patients (r = 0-97) and speech therapists (r = 0.87). The time taken for normal vocal cord function to return ranged from four weeks to one year (mean 13.8 weeks) and was not related to the initial grade or duration of dysphonia at presentation. Full recovery of phonation and vocal cord function was seen in all patients.
In patient 6 betamethasone has been continued for the last seven months, and vocal cord deformity and mild dysphonia (grade I) persist. Likewise resumption of beclomethasone dipropionate inhalation in patient 1 led to a return of the laryngeal abnormality within six weeks, with occasional dysphonia.
There were five dysphonic patients in whom no adduction deformity of the vocal cords was seen at laryngoscopy. Details of these patients are shown in tables 5 and 6. They had milder dysphonia (mean grade 1.1). Three had laryngeal candidiasis. The other two had normal laryngeal appearances but were judged to be tense and anxious, with psychogenic dysphonia. Nine patients (five female) with a mean age of 51 years (range 33-69) have been followed for up to 21 months (mean 13 months) after starting inhaled steroids. Patients were examined at monthly intervals. Four patients were examined before starting inhaled steroids, while the other five had the initial 
Steroid inhalation was continued for the next three months and the abnormality persisted but without symptoms. The drug was then discontinued and one month later the abnormality had disappeared. Beclomethasone dipropionate was then reintroduced at the same daily dose. Ten weeks later the patient became dysphonic and the abnormality was detected at examination two weeks later. The steroid inhalation was again discontinued. Normal phonation returned one week later but the laryngeal abnormality took 14 weeks to resolve.
Discussion
Local complications of inhaled steroids include candidiasis, sore throat, and dysphonia. The interrelationship and pathogenesis of these three conditions have previously not been clear.
We have recognised for the first time a characteristic laryngeal abnormality which appears to underlie most cases of persistent dysphonia. In nine out of 14 patients there was a bilateral vocal cord adduction deformity, the cords assuming a bowed or elliptical appearance during phonation. We believe this deformity to be causal-firstly, because the laryngeal abnormality developed and resolved in parallel with dysphonia and, secondly, because an identical abnormality, "phonasthenia," is a well described cause of dysphonia in myopathic disorders such as myasthenia gravis and dystrophia myotonica. In these conditions there is considered to be a paresis of the phonatory muscles, the internal tensor muscle group being the most commonly affected. Dysphonia arises from failure of the vocal cords to approximate completely during phonation, a gap being left for escape of air. We believe that this abnormality has not previously been recognised in dysphonic patients receiving inhaled steroids for three reasons. Firstly, interest has centred around candidiasis as a cause of dysphonia and laryngoscopy has usually been performed simply to verify or exclude the presence of candidiasis rather than to assess vocal cord mobility. Secondly, until the advent of fibreoptic techniques laryngoscopy has been limited in the conscious patient to an indirect mirror examination, a technique we have found to be inferior for recognising the abnormal laryngeal appearances. Thirdly, direct laryngoscopy with rigid instruments under general anaesthesia cannot assess vocal cord mobility.
Some cases of dysphonia appear to be due to candidiasis without any vocal cord abnormality. In five patients with persistent dysphonia and normal vocal cord mobility, three had laryngeal candidiasis (table 6). We diagnosed the latter when there were typical white, raised plaques with underlying erythema. In two of the three cases fungal cultures for Candida albicans were positive. In the third patient fungal cultures were negative but she was taking an oral antifungal agent at the time of the examination. Candidiasis is a well known complication in patients receiving inhaled steroids. Its reported incidence varies from zero to 91%. This variation depends partly on the diagnostic criteria adopted by the authors and partly on whether single or repeated examinations of the pharynx are made. Candida albicans is part of the normal oropharyngeal flora and has been cultured from throat swabs in 28%22 and 57%23 of normal subjects: hence the diagnosis of candidiasis must be a clinical one. When the strict criteria of typical naked eye appearances together with positive fungal cultures are used, as in our study, the reported incidence of pharyngeal candidiasis is much less variable, although it still shows a range from zero to 32%.. 7 8 162024 As well as being the sole cause of dysphonia, candidiasis may contribute to the vocal cord abnormality by adding an inflammatory component to the myopathic one. Two of our nine patients with vocal cord deformity (table 2) had laryngeal candidiasis.
In some patients with persistent dysphonia no vocal cord deformity or candidiasis is seen. We had two patients in this category. Both appeared unduly tense and anxious and we believe that their dysphonia was psychogenic.
Various mechanisms have been suggested for the occurrence of dysphonia with inhaled steroid treatment, including a non-specific mucosal irritation caused by the freon propellants24 and drying action of the spray. '7 We have shown a consistent vocal cord deformity, however, to underlie most cases of persistent dysphonia. The mechanism of the laryngeal abnormality we believe to be related to the steroid rather than the propellant component of the inhaled steroid preparation. Firstly, the laryngeal adduction deformity resolved after the inhaled steroid had been stopped, even though the total quantity of inhaled propellant was maintained by an appropriate increase in inhaled bronchodilator beta agonist and ipratroprium bromide treatment; the fluorocarbon propellants in aerosols do not differ significantly in either type or quantity. Secondly, resumption of inhaled steroids in two patients (patients 1 and 6) without any increase in total propellant intake led to a return of the abnormality. Thirdly, one patient (patient 5) was taking dry powdered preparations of steroid and bronchodilator, which contain no propellants. In a recent study it was also concluded that dysphonia was due to the steroid rather than the propellant."
In this study it was suggested that vocal cord abuse 819 group.bmj.com on June 23, 2017 -Published by http://thorax.bmj.com/ Downloaded from Williams, Baghat, Stableforth, Cayton, Shenoi, Skinner might be an important contributory factor. But although vocal abuse was present in some of our patients it was no more common than in a control group of medical outpatients.
It is clear that all available inhaled steroid preparations can cause the laryngeal abnormality and that a change to a different one at an equivalent dose is unlikely to influence the problem. Probably the risk of dysphonia due to the adductor vocal cord deformity is related to the total dose and potency of inhaled steroid preparation. For instance, the two patients (8 and 9) taking budesonide, which is two to three times as potent as beclomethasone dipropionate,25 both developed dysphonia less than two weeks after starting the drug; while the patient taking the smallest dose of inhaled steroid, beclomethasone dipropionate 200 ,ug (patient 4), took the longest time (112 weeks) to develop dysphonia. Possibly the vocal cord deformity represents a local steroid myopathy, but we have no direct evidence for this. Interestingly dysphonia is seldom reported in children during inhaled steroid treatment and this may be explained by the use of a lower total daily dose, as has been suggested; '9 perhaps too the anabolic influence of growth counteracts any detrimental myopathic effect of the steroid.
In After discontinuation of the inhaled steroid the laryngeal appearances and the voice invariably returned to normal, although this sometimes took months.
